Neuroprotective versus tumorigenic protein kinase C activators

Trends in Biochemical Sciences

Volumn 34, Issue 3, 2009, Pages 136-145

  Nelson, T J ^a   Alkon, D L ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRYOSTATIN; DIACYLGLYCEROL DERIVATIVE; FARNESYL THIOTRIAZOLE; GNIDIMACRIN; IRIPALLIDAL; LIPID; NAPHTHALENESULFONAMIDE; NEUROPROTECTIVE AGENT; PHORBOL ESTER; POLYUNSATURATED FATTY ACID; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C DELTA; TRIAZOLE DERIVATIVE; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DEGENERATIVE DISEASE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME BINDING; ENZYME REGULATION; HUMAN; LONG TERM MEMORY; NERVE DEGENERATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; STROKE; SYNAPTOGENESIS; TRAUMATIC BRAIN INJURY; TUMOR PROMOTION;

BINDING SITES; BRYOSTATINS; CARCINOGENS; DITERPENES; DOWN-REGULATION; ENZYME ACTIVATION; MODELS, MOLECULAR; NEURODEGENERATIVE DISEASES; PHORBOL ESTERS; PROTEIN KINASE C;

EID: 62849107572     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2008.11.006     Document Type: Review

References (81)

1. Hongpaisan J., and Alkon D.L. A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 19571-19576
2. Sun M.K., and Alkon D.L. Dual effects of bryostatin-1 on spatial memory and depression. Eur. J. Pharmacol. 512 (2005) 43-51
3. Podar K., et al. The therapeutic role of targeting protein kinase C in solid and hematologic malignancies. Expert Opin. Investig. Drugs 16 (2007) 1693-1697
4. Lee H.W., et al. Bryostatin 1 and phorbol ester down-modulate protein kinase C-α and -ε via the ubiquitin/proteasome pathway in human fibroblasts. Mol. Pharmacol. 51 (1997) 439-447
5. Seki T., et al. Phosphorylation of PKC activation loop plays an important role in receptor-mediated translocation of PKC. Genes Cells 10 (2005) 225-239
6. Newton A.C. Protein kinase C: Structural and spatial regulation by phosphorylation, cofactor, and macromolecular interactions. Chem. Rev. 101 (2001) 2353-2364
7. Schechtman D., and Mochly-Rosen D. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20 (2001) 6339-6347
8. Kronfeld I., et al. Phosphorylation of protein kinase Cδ on distinct tyrosine residues regulates specific cellular functions. J. Biol. Chem. 275 (2000) 35491-35498
9. Leontieva O.V., and Black J.D. Identification of two distinct pathways of protein kinase Cα down-regulation in intestinal epithelial cells. J. Biol. Chem. 279 (2004) 5788-5801
10. Prevostel C., et al. Protein kinase Cα actively downregulates through caveolae-dependent traffic to an endosomal compartment. J. Cell Sci. 113 (2000) 2575-2584
11. Zhang G., et al. Crystal structure of the cys2 activator-binding domain of protein kinase Cδ in complex with phorbol ester. Cell 81 (1995) 917-924
12. Jeffrey A.M., and Liskamp R.M. Computer-assisted molecular modeling of tumor promoters: rationale for the activity of phorbol esters, teleocidin B, and aplysiatoxin. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 241-245
13. Wender P.A., et al. Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 7197-7201
14. 3H]bryostatin 4 to protein kinase C. Biochem. Pharmacol. 43 (1992) 2007-2014
15. Lorenzo P.S., et al. Differential roles of the tandem C1 domains of protein kinase Cδ in the biphasic down-regulation induced by bryostatin 1. Cancer Res. 59 (1999) 6137-6144
16. Colón-González F., and Kazanietz M.G. C1 domains exposed: from diacylglycerol binding to protein-protein interactions. Biochim. Biophys. Acta 1761 (2006) 827-837
17. Irie K., et al. Establishment of a binding assay for protein kinase C isozymes using synthetic C1 peptides and development of new medicinal leads with protein kinase C isozyme and C1 domain selectivity. Pharmacol. Ther. 93 (2002) 271-281
18. Giorgione J., et al. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C. Biochemistry 42 (2003) 11194-11202
19. Medkova M., and Cho W. Interplay of C1 and C2 domains of protein kinase C-α in its membrane binding and activation. J. Biol. Chem. 274 (1999) 19852-19861
20. Ananthanarayanan B., et al. Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains. J. Biol. Chem. 278 (2003) 46886-46894
21. Stahelin R.V., et al. Diacylglycerol-induced membrane targeting and activation of protein kinase Cε: mechanistic differences between protein kinases Cδ and Cε. J. Biol. Chem. 280 (2005) 19784-19793
22. Kuzirian A.M., et al. Bryostatin enhancement of memory in Hermissenda. Biol. Bull. 210 (2006) 201-214
23. Marshall J.L., et al. Phase I study of prolonged infusion bryostatin-1 in patients with advanced malignancies. Cancer Biol. Ther. 1 (2002) 409-416
24. Sun M.K., et al. Post-stroke neuronal rescue and synaptogenesis mediated in vivo by PKC in adult brains. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 13620-13625
25. 2+ bridges the C2 membrane-binding domain of protein kinase Cα directly to phosphatidylserine. EMBO J. 18 (1999) 6329-6388
26. Cavallaro S., et al. Late memory-related genes in the hippocampus revealed by RNA fingerprinting. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9669-9673
27. Zhao W., et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 274 (1999) 34893-34902
28. Reuss B., et al. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313 (2003) 139-157
29. Meinhardt G., et al. Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells. Anticancer Drugs 13 (2002) 725-733
30. Terry R.D. Cell death or synaptic loss in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59 (2000) 1118-1119
31. Scheff S.W., et al. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27 (2006) 1372-1384
32. Tomimatsu N., and Arakawa Y. Protein kinase C-mediated protection of motoneurons from excitotoxicity. Neurosci. Lett. 439 (2008) 143-146
33. Jung Y.S., et al. Activation of protein kinase C-δ attenuates kainate-induced cell death of cortical neurons. Neuroreport 16 (2005) 741-744
34. Noh K.M., et al. A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol. Dis. 7 (2000) 375-383
35. Alkon D.L., et al. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease. Trends Pharmacol. Sci. 28 (2007) 51-60
36. Etcheberrigaray R., et al. Therapeutic effect of PKC activators on Alzheimer's disease transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 11141-11146
37. Buxbaum J.D., et al. Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
38. Yang H.Q., et al. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α-secretase activity. Eur. J. Neurosci. 26 (2007) 381-391
39. Choi D.S., et al. PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 8215-8220
40. Greenberg D.A. Another weapon against amyloid. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7943-7944
41. Xu H., et al. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270 (1995) 23243-23245
42. Behrens M.M., et al. Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase. Neuroscience 94 (1999) 917-927
43. Trejo J., et al. A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's β-amyloid precursor protein gene. J. Biol. Chem. 269 (1994) 21682-21690
44. da Cruz E., et al. Enhanced generation of Alzheimer's amyloid-β following chronic exposure to phorbol ester correlates with differential effects on α and ε isozymes of protein kinase C. J. Neurochem. 108 (2009) 319-330
45. Gutcher I., et al. The isoform-specific regulation of apoptosis by protein kinase C. Cell. Mol. Life Sci. 60 (2003) 1061-1070
46. Lallemend F., et al. Activation of protein kinase CßI constitutes a new neurotrophic pathway for deafferented spiral ganglion neurons. J. Cell Sci. 118 (2005) 4511-4525
47. Domeniconi M., et al. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46 (2005) 849-855
48. Ahmed Z., et al. TACE-induced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin. FASEB J. 20 (2006) 1939-1941
49. Bonini J.S., et al. On the participation of hippocampal PKC in acquisition, consolidation and reconsolidation of spatial memory. Neuroscience 147 (2007) 37-45
50. Kozikowski A.P., et al. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCδ and discovery of an ILV analogue of improved isozyme selectivity. J. Med. Chem. 40 (1997) 1316-1326
51. Saraiva L., et al. Characterization of phorbol esters activity on individual mammalian protein kinase C isoforms, using the yeast phenotypic assay. Eur. J. Pharmacol. 491 (2004) 101-110
52. Lu Z., et al. Tumor promotion by depleting cells of protein kinase Cδ. Mol. Cell. Biol. 17 (1997) 3418-3428
53. Scaglione-Sewell B., et al. Decreased PKC-α expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. Cancer Res. 58 (1998) 1074-1081
54. Mandil R., et al. Protein kinase Cα and protein kinase Cδ play opposite roles in the proliferation and apoptosis of glioma cells. Cancer Res. 61 (2001) 4612-4619
55. Ryer E.J., et al. Protein kinase Cδ induces apoptosis of vascular smooth muscle cells through induction of the tumor suppressor p53 by both p38-dependent and p38-independent mechanisms. J. Biol. Chem. 280 (2005) 35310-35317
56. Griner E.M., and Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 7 (2007) 281-294
57. Jackson D.N., and Foster D.A. The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival. FASEB J. 18 (2004) 627-636
58. Harper N., et al. Protein kinase C modulates tumor necrosis factor-related apoptosis- inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling. J. Biol. Chem. 278 (2003) 44338-44347
59. Byun H.S., et al. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C. Mol. Pharmacol. 70 (2006) 1099-1108
60. Kilpatrick L.E., et al. Selective regulation by δ-PKC and PI3-kinase in the assembly of the antiapoptotic TNFR-1 signaling complex in neutrophils. Am. J. Physiol. Cell Physiol. 287 (2004) C633-C642
61. Reyland M.E. Protein kinase Cδ and apoptosis. Biochem. Soc. Trans. 35 (2007) 1001-1004
62. Malumbres M., and Carnero A. Cell cycle deregulation: a common motif in cancer. Prog. Cell Cycle Res. 5 (2003) 5-18
63. Black J.D. Protein kinase C-mediated regulation of the cell cycle. Front. Biosci. 5 (2000) D406-D423
64. Nakashima S. Protein kinase Cα (PKCα): regulation and biological function. J. Biochem. 132 (2002) 669-675
65. Livneh E., and Fishman D. Linking protein kinase C to cell-cycle control. Eur. J. Biochem. 248 (1997) 1-9
66. Gavrielides M.V., et al. Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr. Drug Targets 5 (2004) 431-443
67. Kedei N., et al. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 64 (2004) 3243-3255
68. Vogg G., et al. Tumor promoting diterpenes from Euphorbia leuconeura L. Phytochemistry 51 (1999) 289-295
69. Fujiki H., and Sugimura T. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Adv. Cancer Res. 49 (1987) 223-264
70. Irie K., et al. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes. Curr. Pharm. Des. 10 (2004) 1371-1385
71. Yoshida M., et al. Mechanism of antitumor action of PKC activator, gnidimacrin. Int. J. Cancer 77 (1998) 243-250
72. Shao L., et al. Iridals are a novel class of ligands for phorbol ester receptors with modest selectivity for the RasGRP receptor subfamily. J. Med. Chem. 44 (2001) 3872-3880
73. Gilbert B.A., et al. Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. Biochemistry 34 (1995) 3916-3920
74. Lee J., et al. Branched diacylglycerol-lactones as potent protein kinase C ligands and α-secretase activators. J. Med. Chem. 49 (2006) 2028-2036
75. ++-sensitive protein kinase. Biochem. Biophys. Res. Commun. 148 (1987) 776-782
76. Kanno T., et al. The linoleic acid derivative DCP-LA selectively activates PKC-ε, possibly binding to the phosphatidylserine binding site. J. Lipid Res. 47 (2006) 1146-1150
77. Shearman M.S., et al. Selective activation of the γ-subspecies of protein kinase C from bovine cerebellum by arachidonic acid and its lipoxygenase metabolites. FEBS Lett. 243 (1989) 177-182
78. Ito M., et al. N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide, a novel activator of protein kinase C. Biochemistry 25 (1986) 4179-4184
79. Takekoshi S., et al. Activation of protein kinase C by oxidized diacylglycerols. Biochem. Biophys. Res. Commun. 217 (1995) 654-660
80. Kawahara Y., et al. Activation of protein kinase C by the action of 9,11-epithio-11,12- methano-thromboxane A2 (STA2), a stable analogue of thromboxane A2, in human platelets. Thromb. Res. 41 (1986) 811-818
81. Mitra J., and Enders G.H. Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene 23 (2004) 3361-3367